Researchers discover new type of microglia related to stroke in the ischemia/reperfusion injured brain

A research team, affiliated with UNIST has identified a new type of microglia associated with stroke in the ischemia/reperfusion (I/R) injured brain. This breakthrough has been led by Professor Sung Ho Park and his research team in the Department of Biological Sciences at UNIST, in collaboration with a research team, led by Professor Goo Taeg Oh from Ewha Womans University.

Microglia, the primary immune cells in the central nervous system (CNS), are known to eliminate unwanted germs and debris and remove dying neurons. In this study, the research team classified a new type of microglia with enhanced antioxidant function and markers similar to those of disease-associated microglia (DAM), designated them as stroke-associated microglia (SAM).

Through animal experiments, the research team demonstrated that the presence of the typical antioxidant gene, Peroxiredoxin-1 (Prdx1), protects against acute I/R injury and is required for SAM activation and the consequent reduction of microglial cell death and inflammatory responses.

In addition, after performing transient middle cerebral artery occlusion (tMCAO) surgery to induce ischemic stroke in mice, the research team found that Prdx1−/− mice were more severely injured by acute I/R injury, as confirmed by TTC staining, neurological deficit scores, motor tests, and the survival rate, indicating that Prdx1 has a protective function.

In this study, we have, for the first time, identified a specialized and distinctive type of microglia with enhanced antioxidant function in stroke mice. Prdx1-dependent SAM may be a potential biomarker and therapeutic target for protecting microglial function and treating brain I/R injury," He adds, "Although this new cluster will require further study, our findings provide a new perspective that Prdx1-mediated microglial heterogeneity is important in ischemic stroke."

Professor Sung Ho Park, UNIST

This study has been jointly participated by Wonhyo Lee, a doctoral researcher within the Department of Biological Sciences at UNIST and Sinai Kim, a doctoral researcher within the Department of Life Sciences at Ewha Womans University, as first authors.

Their findings have been published in the August 2022 issue of Redox Biology, a renowned journal in the areas of both health and disease. This study was carried out with the support of the National Research Foundation of Korea (NRF).

Source:
Journal reference:

Kim, S., et al. (2022) The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic stroke. Redox Biology. doi.org/10.1016/j.redox.2022.102347.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study unveils why glioblastoma becomes resistant to treatment